Elizabeth Henderson, PhDScientist II at XencorSpeaker
Profile
Elizabeth completed her BSc at the University of Utah in 2010, followed by a Master of Business and Science (MBS) in 2014 and a PhD in 2019 from the Keck Graduate Institute. She further honed her expertise through postdoctoral research at City of Hope and joined Xencor in 2021. Her current work centers on pioneering in vivo antibody discovery methods, contributing to the advancement of Xencor’s diverse pipeline of antibody-based therapeutics.
Agenda Sessions
Early Career Scientist Presentation #2: Development of MICA/B Antibodies for Cancer Treatment
, 10:25amView Session